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*Propionibacterium acnes* is known as a Gram-positive bacterium constituting a significant part of the human skin microbiota ([@B1]). Its natural habitat is mainly the lipid-rich sebaceous glands ([@B2], [@B3]). Acne vulgaris is a common chronic skin disease and is usually associated with the detection of this organism. Moreover, *P. acnes* is more frequently identified in device-related infections ([@B4], [@B5]), producing biofilm in this context ([@B6]). Recently, this species has been subdivided into several phylogenetic types that were subsequently afforded subspecies status ([@B7]).

We present here the genome sequence of *Propionibacterium namnetense* NTS 31307302^T^ isolated at Nantes University Hospital, France, during a bone infection ([@B8]). The isolate showed beta-hemolysis on a blood agar plate and was recently described as being related to *P. acnes* ([@B9]). Strain NTS 31307302^T^ is resistant to rifampin, as it has been already reported for *in vitro*-selected mutants ([@B10]) or clinical strains of *P. acnes* involved in biofilm or device-related infections ([@B11]).

*P. namnetense* NTS 31307302^T^ was grown overnight at 37°C on a Schaedler agar plate (Oxoid, United Kingdom) under an anaerobic atmosphere. Genomic DNA was extracted using a DNeasy blood and tissue kit (Qiagen Gmbh, Germany), according to the provider's recommendation. A paired-end library was prepared with the NEBNext Ultra DNA library prep kit for Illumina (NEB) and sequenced (2 × 150 bp) on a MiSeq Sequencer (Illumina, USA). *De novo* assembly was performed with Velvet 1.2.10 and VelvetOptimiser 2.2.5 (optimal hash value, 127). A total of 2,846,458 reads were assembled into 24 contigs (15 of them \>1 kb) with an average coverage of 127×. Contig reordering and annotation were performed with Mauve 2.3.1 ([@B12]) and the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) ([@B13]), respectively. Average nucleotide identities (ANI) were calculated using Oat 0.91 ([@B14]).

The final assembly has a total length of 2,369,664 bp, an *N*~50~ of 626 kb, and a G+C content of 60.5%. About 2,136 coding sequences (CDSs), 46 tRNAs, 84 pseudogenes, three rRNAs, and three noncoding RNAs were revealed by annotation.

To determine genomic differences between *P. namnetense* NTS 31307302^T^ and the closely related *P. acnes* KPA171202, ATCC 11828, and ATCC 6919^T^, we performed a genomic comparison. The draft genome size of the newly sequenced strain is 2.37 Mb, which is 5.02 to 9.81% smaller than *P. acnes* reference strains. The ANI value was 88.5%. Interestingly, our strain showed an ANI value of 99.52% with *P. acnes* SK182B-JCVI (accession no. AFUN00000000.1), recovered during the Human Microbiome Project, which is significantly above the cutoff value of 95% for species delineation ([@B14]). Therefore, this strain is likely to be another isolate of this species. Comparing both sequences of the *rpoB* gene, we observed only one point mutation at nucleotide 1319 (G→A) in strain NTS 31307302^T^ leading to an amino acid modification at position 440 (R440H), previously described to be involved in rifampin resistance in *P. acnes* ([@B11]).

This draft genome of *P. namnetense* NTS 31307302^T^ will be used for studying virulence features associated with bone infection, especially hemolysin, lipase, or hyaluronidase ([@B15]).
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The draft sequence of *P. namnetense* NTS 31307302^T^ studied in this project has been deposited at DDBJ/EMBL/GenBank under the accession no. [LWHO01000001](http://www.ncbi.nlm.nih.gov/nuccore/LWHO01000001). The version described in this paper is LWHO01000001.1.
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